Abstract:Background and aims Endoscopic full-thickness resection (EFTR) has been increasingly applied in the treatment of gastric submucosal tumors (G-SMTs) with explorative intention. This study aimed to compare the efficacy, tolerability, and clinical outcomes of EFTR and surgical intervention for the management of muscularis propria (MP)-derived G-SMTs. Methods Between September 2011 and May 2019, the clinical records of patients with MP-derived G-SMTs undergoing EFTR at our endoscopic unit were collected. A cohort of people with primary MP-derived G-SMTs treated by surgery was matched in a 1:1 ratio to EFTR group with regard to patients’ baseline characteristics, clinicopathologic features of the tumor and the procedure date. The perioperative outcomes and follow-up data were analyzed. Results In total, 62 and 62 patients were enrolled into the surgery and EFTR group, respectively, with median follow-up of 786 days. The size of G-SMTs (with ulceration) ranged from 10 to 90 mm. For patients with tumor smaller than 30 mm, surgery and EFTR group presented comparable procedural success rate (both were 100%), en bloc resection rate (100% vs. 94.7%), tumor capsule rupture rate (0% vs. 5.3%), and pathological R0 resection rate (both were 100%). EFTR had a statistically significant advantage over surgery for estimated blood loss (3.12 ± 5.20 vs. 46.97 ± 60.73 ml, p ≤ 0.001), discrepancy between the pre- and postprocedural hemoglobin level (5.18 ± 5.43 vs. 9.84 ± 8.25 g/L, p = 0.005), bowel function restoration [1 (0–5) vs. 3 (1–5) days, p ≤ 0.001], and hospital cost (28,617.09 ± 6720.78 vs. 33,963.10 ± 13,454.52 Yuan, p = 0.033). The patients with tumor larger than 30 mm showed roughly the same outcomes after comparison analysis of the two groups. However, the clinical data revealed lower en bloc resection rate (75.0% vs. 100%, p = 0.022) and higher tumor capsule rupture rate (25.0% vs. 0%, p = 0.022) for EFTR when compared to surgery. The procedure time, duration of postprocedural fasting and antibiotics usage, and hospital stay of the two groups were equivalent. The occurrence rate of adverse events within postoperative day 7 were 74.2% and 72.6% after EFTR and surgery, respectively ( p = 1.000). No complications occurred during the follow-up. Conclusion For treatment of MP-derived G-SMTs (with or without ulceration), our study showed the feasibility and safety of EFTR, which also provided better results in terms of procedural blood loss, the postoperative bowel function restoration and cost-effectiveness when compared to surgery, whereas the surgery was superior in en bloc resection rate for G-SMTs larger than 30 mm. The postprocedural clinical outcomes seemed to be equivalent in these two resection methods.

A Real-World Promising Result of Endoscopic Full-Thickness Resection: It's Time for Endoscopic Full-Thickness Resection to Be Widely Used.

A Real-World Promising Result of Endoscopic Full-Thickness Resection: It's Time for Endoscopic Full-Thickness Resection to Be Widely Used

Endoscopic Full-thickness Resection (EFTR) for Gastrointestinal Subepithelial Tumors

Colon Sparing Endoscopic Full-Thickness Resection for Advanced Colorectal Lesions: Is It Time for Global Adoption?

Resection of the Gastric Submucosal Tumor (G-SMT) Originating from the Muscularis Propria Layer: Comparison of Efficacy, Patients' Tolerability, and Clinical Outcomes Between Endoscopic Full-Thickness Resection and Surgical Resection

Endoscopic Full‐thickness Resection, Indication, Methods and Perspectives

Endoscopic Full‐thickness Resection for Gastrointestinal Submucosal Tumors

Endoscopic full thickness resection: techniques, applications, outcomes

Endoscopic full-thickness resection: circumferential cutting method

Endoscopic Full-Thickness Resection (EFTR) Without Laparoscopic Assistance for Nonampullary Duodenal Subepithelial Lesions: Our Clinical Experience of 32 Cases

Safety and efficacy of a modified endoscopic full-thickness resection technique for gastric submucosal tumors: a case series

Endoscopic Resection Of Upper Gastrointestinal Subepithelial Tumors: Promising New Endoscopic Techniques-Are They Here To Stay?

Current status of endoscopic full-thickness resection for treatment of colorectal neoplastic lesions

Feasibility and safety of endoscopic full‐thickness resection for submucosal tumors in the upper gastrointestinal tract, including predominantly extraluminal submucosal tumors (with video)

Mo1977 Clinical Outcomes of Endoscopic Full-Thickness Resection for Non-Ampullary Duodenal Submucosal Tumors

Concerns about the study of Yzet et al. on treatment of residual colorectal neoplasia after endoscopic resection

Endoscopic resection using the new duette multiband mucosectomy kit for esophageal disease

A large multicenter cohort on the use of full-thickness resection device for difficult colonic lesions

Effects Analysis of Endoscopic Submucosal Tunnel Dissection in Treatment of Upper Gastrointestinal Tumor

New Method of Endoscopic Full-Thickness Resection: a Pilot Study of Non-Exposed Endoscopic Wall-Inversion Surgery in an Ex Vivo Porcine Model

Sa1504 Clinical Value of Endoscopic Full-Thickness Resection for the Treatment of Colonic Submucosal Tumors Originating from the Muscularis Propria: a Prospective Sigle-Center Study